- Home
- SBFM vs MEGL Comparison
SBFM vs MEGL Comparison
Compare SBFM & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- MEGL
- Stock Information
- Founded
- SBFM 2006
- MEGL 2016
- Country
- SBFM United States
- MEGL Hong Kong
- Employees
- SBFM N/A
- MEGL N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- MEGL Finance: Consumer Services
- Sector
- SBFM Health Care
- MEGL Finance
- Exchange
- SBFM Nasdaq
- MEGL Nasdaq
- Market Cap
- SBFM 6.6M
- MEGL 6.8M
- IPO Year
- SBFM N/A
- MEGL 2022
- Fundamental
- Price
- SBFM $1.50
- MEGL $1.58
- Analyst Decision
- SBFM Strong Buy
- MEGL
- Analyst Count
- SBFM 1
- MEGL 0
- Target Price
- SBFM $15.00
- MEGL N/A
- AVG Volume (30 Days)
- SBFM 44.5K
- MEGL 109.8K
- Earning Date
- SBFM 11-04-2025
- MEGL 10-29-2025
- Dividend Yield
- SBFM N/A
- MEGL N/A
- EPS Growth
- SBFM N/A
- MEGL N/A
- EPS
- SBFM N/A
- MEGL N/A
- Revenue
- SBFM $36,341,741.00
- MEGL $1,645,862.00
- Revenue This Year
- SBFM $32.20
- MEGL N/A
- Revenue Next Year
- SBFM $32.74
- MEGL N/A
- P/E Ratio
- SBFM N/A
- MEGL N/A
- Revenue Growth
- SBFM 19.22
- MEGL N/A
- 52 Week Low
- SBFM $1.17
- MEGL $1.02
- 52 Week High
- SBFM $3.90
- MEGL $5.52
- Technical
- Relative Strength Index (RSI)
- SBFM 56.84
- MEGL 61.85
- Support Level
- SBFM $1.35
- MEGL $1.30
- Resistance Level
- SBFM $1.45
- MEGL $1.80
- Average True Range (ATR)
- SBFM 0.07
- MEGL 0.13
- MACD
- SBFM 0.01
- MEGL 0.03
- Stochastic Oscillator
- SBFM 82.39
- MEGL 56.00
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.